Vaisala Group
Vaisala Corporation: Managers’ Transactions – Rosenberg, Lotte
Vaisala Corporation: Managers’ Transactions – Rosenberg, Lotte
Vaisala Corporation
Managers’ Transactions
December 20, 2024, at 11:30 a.m. (EET)
Vaisala Corporation: Managers’ Transactions – Rosenberg, Lotte
____________________________________________
Person subject to the notification requirement
Name: Rosenberg, Lotte
Position: Member of the Board/Deputy member
Issuer: Vaisala Oyj
LEI: 743700RNDD7KU11HW873
Notification type: INITIAL NOTIFICATION
Reference number: 88612/6/6
____________________________________________
Transaction date: 2024-12-19
Venue: TQEA
Instrument type: SHARE
ISIN: FI0009900682
Nature of the transaction: DISPOSAL
Transaction details
(1): Volume: 4 Unit price: 46.65 EUR
(2): Volume: 8 Unit price: 46.65 EUR
(3): Volume: 23 Unit price: 46.5 EUR
(4): Volume: 51 Unit price: 46.65 EUR
(5): Volume: 51 Unit price: 46.65 EUR
(6): Volume: 49 Unit price: 46.7 EUR
(7): Volume: 214 Unit price: 46.65 EUR
Aggregated transactions
(7): Volume: 400 Volume weighted average price: 46.6475 EUR
More information
Paula Liimatta
+358 9 8949 2020, ir@vaisala.com
Distribution
Nasdaq Helsinki
Key media
vaisala.com
Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of over 2,300 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange. vaisala.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
VALLOUREC8.7.2025 07:30:00 CEST | Press release
Vallourec Secures Two OCTG Contracts in Iraq with CNOOC and with PetroChina
Basilea Pharmaceutica AG, Allschwil8.7.2025 07:15:00 CEST | Press release
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Novartis Pharma AG8.7.2025 07:15:00 CEST | Press release
Novartis receives approval for first malaria medicine for newborn babies and young infants
dsm-firmenich8.7.2025 07:00:00 CEST | Press release
Weekly progress on share repurchase program to cover share plans and reduce capital
Corbion8.7.2025 07:00:00 CEST | Press release
Corbion announces Executive Committee changes to strengthen its leadership structure
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom